Skip to main content
. 2023 Mar 2;15(3):820. doi: 10.3390/pharmaceutics15030820

Table 2.

Single-factor optimization: process and formulation.

Value Size PDI Zeta
L-HA–PDM DM (μL) 100 445.99 ± 16.94 0.51 ± 0.16 −36.98 ± 2.41
300 272.53 ± 8.32 0.32 ± 0.04 −31.64 ± 3.09
500 276.06 ± 10.42 0.29 ± 0.04 −32.08 ± 1.98
KPS (mL) 0.5 340.11 ± 13.16 0.46 ± 0.06 −37.29 ± 2.19
1.5 255.68 ± 12.94 0.26 ± 0.05 −31.58 ± 1.97
2.5 522.62 ± 14.39 0.33 ± 0.13 −23.42 ± 2.05
Stirring speed (rpm) 1040 577.09 ± 15.92 0.34 ± 0.13 −32.27 ± 1.97
1300 324.18 ± 11.68 0.22 ± 0.08 −31.64 ± 1.67
1560 451.67 ± 9.97 0.21 ± 0.07 −34.92 ± 2.21
Temperature (°C) 50 250.48 ±17.97 0.17 ± 0.07 −42.02 ± 4.02
60 286.22 ± 18.66 0.15 ± 0.11 −40.68 ± 4.19
70 445.99 ± 16.94 0.51 ± 0.16 −36.98 ± 2.41
M-HA-PDM DM (μL) 100 534.02 ±25.64 0. 62 ± 0.18 −33.96 ± 2.89
300 762.46 ± 19.64 0.54 ± 0.13 −36.39 ± 2.06
500 453.04 ± 15.62 0.32 ± 0.09 −34.88 ± 2.14
KPS (mL) 0.5 728.25 ± 17.69 0.33 ± 0.11 −36.92 ± 2.01
1.5 443.11 ± 15.21 0.28 ± 0.09 −38.57 ± 1.97
2.5 412.67 ± 12.71 0.23 ± 0.08 −35.04 ± 2.15
Stirring speed (rpm) 1040 292.07 ± 11.29 0.24 ± 0.05 −33.84 ± 2.67
1300 264.82 ± 11.06 0.16 ± 0.08 −34.02 ± 2.81
1560 437.43 ± 10.11 0.21 ± 0.07 −38.59 ± 2.09
Temperature (°C) 50 452.39 ± 13.42 0.19 ± 0.08 −27.99 ± 1.87
60 262.59 ± 10.97 0.15 ± 0.04 −36.52 ± 3.14
70 269.55 ± 10.67 0.16 ± 0.04 −26.98 ± 1.62
H-HA–PDM DM (μL) 100 452.37 ± 19.64 0.67 ± 0.21 −28.64 ± 2.61
300 304.62 ±16.35 0.33 ± 0.16 −32.05 ± 2.01
500 287.88 ± 12.62 0.47 ± 0.11 −28.64 ± 1.99
KPS (mL) 0.5 557.41 ± 16.98 0.38 ± 0.10 −38.65 ± 2.23
1.5 400.21 ± 14.62 0.32 ± 0.08 −41.02 ± 1.97
2.5 239.11 ± 10.98 0.24 ± 0.05 −37.88 ± 2.09
Stirring speed (rpm) 1040 306.13 ± 15.09 0.22 ± 0.09 −30.94 ± 2.64
1300 332.82 ± 12.01 0.18 ± 0.05 −26.48 ± 1.96
1560 277.98 ± 10.93 0.14 ± 0.04 −29.54 ± 1.89
Temperature (°C) 50 592.59 ± 18.19 0.16 ± 0.07 −34.62 ± 3.01
60 395.92 ± 10.67 0.15 ± 0.08 −31.82 ± 1.67
70 275.24 ± 8.00 0.14 ± 0.05 −25.61 ± 1.98